Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34
United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Phillip Pang
2 Jan 2024
EVP & Chief Medical Officer
Exercised, kept
47,591
$1.53
$72.81K
Phillip Pang
2 Jan 2024
EVP & Chief Medical Officer
Exercised, kept
13,576
$1.58
$21.38K
Phillip Pang
2 Jan 2024
EVP & Chief Medical Officer
Exercised, kept
18,833
$0.86
$16.10K
Herbert Virgin
9 Aug 2022
EVP, Research & CSO
Exercised, kept
7,916
$10.40
$82.29K
Herbert Virgin
9 Aug 2022
EVP, Research & CSO
Exercised, kept
70,177
$1.53
$107.37K
Showing 250 of 462 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 435
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 76
Sales on a Rule 10b5-1 plan 84
Sales straight out of an exercise 130
Sales at will 217
Transactions with no price 0
Shares from compensation/vesting 178,543,571
Sales filed before the plan box existed 178
History held since 10 Oct 2019